Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT) — Inder S. Anand (2003) | RDL Network
Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
Article 2003 en
Authors
IA
Inder S. Anand
LF
Lloyd D. Fisher
YC
YannTong Chiang
Abstract
1 min read
Not only are plasma BNP and NE important predictors of heart failure M&M, but changes in these neurohormones over time are associated with corresponding changes in M&M. These data further reinforce their role as significant surrogate markers in HF and underscore the importance of including their measurement in HF trials.
Inder S. Anand, Michael A. Kuskowski, Thomas S. Rector, Viorel G. Florea, Robert Glazer, Allen Hester, Yann Tong Chiang, Nora Aknay, Aldo Maggioni, Cristina Opasich, Roberto Latini, Jay N. Cohn
Discussion(0)
No comments yet. Be the first to comment.